IRAK1 and central nervous system cancer: As illustrated in Table 2, the result verified that IRAK1 expression level has a significantly positive association with tumor recurrence (p = 0.001) and higher pathological grade (p = 0.037), suggesting that IRAK1 might play a tumor-promoting role in glioma.